Oral supplementation with Lactobacillus rhamnosus CGMCC 1.3724 prevents development of atopic dermatitis in NC/NgaTnd mice possibly by modulating local production of IFN-gamma.

Source:http://linkedlifedata.com/resource/pubmed/id/19555432

Download in:

View as

General Info

PMID
19555432